76 related articles for article (PubMed ID: 8333190)
1. [DNA-binding blood proteins in hemoblastoses].
Egorova VA; Blinov MN
Vopr Med Khim; 1993; 39(3):36-8. PubMed ID: 8333190
[TBL] [Abstract][Full Text] [Related]
2. [Polyadenylate polymerase in blood serum from hemoblastosis patients].
Egorova VA; Blinov MN; Abdulkadyrov KM
Vopr Med Khim; 1994; 40(1):27-9. PubMed ID: 8122405
[TBL] [Abstract][Full Text] [Related]
3. [Modification of complement components under the effect of cationic proteins from leukocytes from donors and leukemia patients].
Rybakova LP; Tiagotin IuV; Goncharova SV; Kulikova IN; Trofimov AV
Vopr Med Khim; 1993; 39(5):38-41. PubMed ID: 8279141
[TBL] [Abstract][Full Text] [Related]
4. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; GodÃnez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
8. [The importance of studies of the glycosaminoglycans in the peripheral blood leukocytes of patients in the diagnosis of the phases of chronic myeloleukemia].
Kharchenko MF; Bessmel'tsev SS; Rukavitsyn OA; Abdulkadyrov KM; Bitiukova ES; Blinov MN
Ter Arkh; 1997; 69(7):21-6. PubMed ID: 9424753
[TBL] [Abstract][Full Text] [Related]
9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
10. [Nuclear proteins of human leukocytes in health and in chronic leukemias].
Rybakova LP
Vopr Onkol; 1993; 39(7-12):282-7. PubMed ID: 7825298
[TBL] [Abstract][Full Text] [Related]
11. [The blood serum albumin transport function in patients with acute and chronic leukemias].
Litvinov AV; Savchenko VG; Tsepova EL; Chemodurova LN
Ter Arkh; 1998; 70(7):72-4. PubMed ID: 9742644
[TBL] [Abstract][Full Text] [Related]
12. Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia.
Giles FJ; DeAngelo DJ; Baccarani M; Deininger M; Guilhot F; Hughes T; Mauro M; Radich J; Ottmann O; Cortes J
Semin Oncol; 2008 Feb; 35(1 Suppl 1):S1-17; quiz S18-20. PubMed ID: 18346528
[TBL] [Abstract][Full Text] [Related]
13. [Certain biochemical features of leukocytes in blast crisis of chronic myelogenous leukemia].
Kharchenko MF; Rybakova LP; Filanovskaia LI; Saltykova LB; Bitiukova ES; Shcherbakova EG; Rukavitsyn OA; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MM
Vopr Med Khim; 1998; 44(3):274-80. PubMed ID: 9703628
[TBL] [Abstract][Full Text] [Related]
14. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
[TBL] [Abstract][Full Text] [Related]
15. WT1-specific serum antibodies in patients with leukemia.
Gaiger A; Carter L; Greinix H; Carter D; McNeill PD; Houghton RL; Cornellison CD; Vedvick TS; Skeiky YA; Cheever MA
Clin Cancer Res; 2001 Mar; 7(3 Suppl):761s-765s. PubMed ID: 11300470
[TBL] [Abstract][Full Text] [Related]
16. [Blast crisis of chronic myelocytic leukemia that was difficult to differentiate from Ph+ acute lymphoblastic leukemia].
Kaneko J; Uchiyama T; Oyake T; Enomoto S; Ono Y; Sugawara T; Numaoka H; Shimosegawa K; Itoh S; Murai K; Ishida Y; Kuriya S
Rinsho Ketsueki; 1999 Nov; 40(11):1174-80. PubMed ID: 10624128
[TBL] [Abstract][Full Text] [Related]
17. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
18. [The monitoring of residual disease for chronic myelogenous leukemia patients treated with imatinib mesylate: detection of T315I mutation in ATP binding site of BCR/ABL gene].
Miyanishi S; Umeki K; Hayashi T; Fukutsuka K; Okumura A; Kishimori C
Rinsho Byori; 2003 Oct; 51(10):1023-9. PubMed ID: 14653203
[TBL] [Abstract][Full Text] [Related]
19. [Cationic proteins and the phagocytic activity of eosinophils in patients with chronic myeloleukemia and eosinophilic-type leukemoid reactions].
Romanova AF; Diagil' IS
Vrach Delo; 1988 Nov; (11):60-1. PubMed ID: 3238981
[No Abstract] [Full Text] [Related]
20. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
